Approval · Notice of Compliance 279 · 2004
VISUDYNE: Notice of Compliance 279
Issued March 25, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 279
- Date
- March 25, 2004
- Company
- Qlt Inc.Vancouver, BC, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: presumed ocular histoplasmosis
- Therapeutic class
- Photosensitizing agent for age-related macular degeneration and pathologic myopia
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VISUDYNE | Not yet assigned | — |
Medicinal ingredients
- VERTEPORFIN 15 MG per VIAL